Hjem › Kronisk myeloid leukæmi › Washington › Seattle
Kronisk myeloid leukæmi kliniske forsøg i Seattle, WA
11 studier for Kronisk myeloid leukæmi søger deltagere på steder i og omkring Seattle (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.
Officiel studietekst (engelsk)
Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
- Swedish Medical Center-Ballard Campus, Seattle
- Swedish Medical Center-Cherry Hill, Seattle
- Swedish Medical Center-First Hill, Seattle
- og 1 flere
Study of Olverembatinib (HQP1351) in Patients With CML-CP
RekruttererFase 3
- Ascentage Investigative Site #1806, Seattle
- Ascentage Investigative Site #1510, Seattle
Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP
RekruttererFase 2
- Seattle Childrens Hospital, Seattle
Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Diseases
RekruttererFase 2
- Fred Hutch/University of Washington Cancer Consortium, Seattle
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
RekruttererObservationsstudie
- Fred Hutchinson Cancer Research Center, Seattle
Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies
RekruttererFase 2Frivillige med god helbredstilstand velkomne
- Fred Hutch/University of Washington Cancer Consortium, Seattle
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
RekruttererFase 1
- Fred Hutch/University of Washington Cancer Consortium, Seattle
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
RekruttererFase 2
- Fred Hutchinson Cancer Center, Seattle
A Phase 1/2 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of TERN-701 in Participants With Chronic Myeloid Leukemia (CARDINAL)
RekruttererFase 1/2
- Fred Hutchinson Cancer Center, Seattle
Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL
RekruttererFase 1
- Fred Hutchinson Cancer Research Center, Seattle
TGRX-678 US Phase I for Subjects with Refractory or Advanced Chronic Myelogenous Leukemia
RekruttererFase 1
- Fred Hutchinson Cancer Center, Seattle
Kronisk myeloid leukæmi forsøg i andre byer
- Houston, TX18 studier
- New York City, NY11 studier
- Detroit, MI6 studier
- Birmingham, AL6 studier
- Philadelphia, PA6 studier
- Chicago, IL6 studier
- Baldwin Park, CA6 studier
- Portland, OR6 studier
- Nashville, TN5 studier
- Columbus, OH5 studier
- Milwaukee, WI5 studier
- Baltimore, MD5 studier
Andre studier i Seattle
- Ikke-småcellet lungecancer53 studier
- Kræft (alle typer)49 studier
- Prostatakræft42 studier
- Akut myeloid leukæmi40 studier
- Brystkræft39 studier
- Metastatisk cancer39 studier
- Colorektal kræft34 studier
- Lungecancer33 studier
- Ægstockræft30 studier
- Multipelt myelom22 studier
- Myelodysplastiske syndromer21 studier
- Akut lymfoblastisk leukæmi21 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.